JP Morgan Chase
DVAX

JP Morgan Chase’s Dynavax Technologies DVAX Stock Holding History

JP Morgan Chase’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-121,800
Closed -$481K – 5086
2016
Q4 		$481K Hold
121,800
– – ﹤0.01% 3789
2016
Q3 		$1.28M Buy
+121,800
New +$1.75M ﹤0.01% 3016

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's DVAX Position: Q1 2026 in Review

JP Morgan Chase sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 674,643 shares — an estimated $10.4M sold.

JP Morgan Chase first reported a position in DVAX in Q2 2013 and held it in 44 quarters. The position peaked at $12.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • JP Morgan Chase reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 674,643 Dynavax Technologies shares in Q1 2026, an estimated $10.4M.
  • JP Morgan Chase first reported a position in Dynavax Technologies in Q2 2013 and held it in 44 quarters.
  • JP Morgan Chase's Dynavax Technologies position peaked at $12.1M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.